Mark Massaro
Stock Analyst at BTIG
(3.94)
# 1,850
Out of 4,639 analysts
1034
Total ratings
39.4%
Success rate
5.7%
Average return
Main Sectors:
Stocks Rated by Mark Massaro
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| TKNO Alpha Teknova | Upgraded: Buy | $8 | $6.72 | +19.05% | 13 | Aug 11, 2026 | |
| NTRA Natera | Reiterated: Buy | $290 → $320 | $318.35 | +0.52% | 80 | Aug 7, 2026 | |
| CAI Caris Life Sciences | Reiterated: Buy | $32 → $33 | $23.40 | +41.03% | 8 | Aug 7, 2026 | |
| CDNA CareDx | Reiterated: Buy | $45 → $60 | $47.07 | +27.47% | 34 | Aug 6, 2026 | |
| BLLN BillionToOne | Reiterated: Buy | $142 → $130 | $98.65 | +31.78% | 7 | Aug 6, 2026 | |
| XGN Exagen | Reiterated: Buy | $8 → $9 | $6.64 | +35.54% | 26 | Aug 5, 2026 | |
| SOPH SOPHiA GENETICS | Reiterated: Buy | $8 → $9 | $7.67 | +17.34% | 19 | Aug 5, 2026 | |
| WGS GeneDx Holdings | Reiterated: Buy | $90 | $77.88 | +15.56% | 37 | Aug 4, 2026 | |
| CSTL Castle Biosciences | Reiterated: Buy | $40 → $44 | $32.35 | +36.01% | 35 | Aug 3, 2026 | |
| TEM Tempus AI | Reiterated: Buy | $80 → $70 | $55.06 | +27.13% | 11 | Aug 3, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $190 → $195 | $167.21 | +16.62% | 49 | Jul 31, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $24 → $25 | $25.45 | -1.77% | 43 | Jul 30, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $16.63 | - | 35 | Jul 28, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $11 → $16 | $14.50 | +12.07% | 38 | Jul 20, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $4.77 | - | 23 | May 15, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $2.5 | $0.9611 | +160.12% | 24 | May 15, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $1.21 | - | 29 | May 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $7 → $4 | $0.454 | +781.06% | 14 | May 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | $4 | $2.52 | +58.73% | 24 | May 1, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Sell | $9 → $5 | $7.65 | -34.64% | 27 | Mar 12, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $160 | $74.83 | +113.82% | 12 | Feb 26, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $830 → $800 | $595.76 | +34.28% | 60 | Feb 3, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $1.16 | - | 19 | Aug 22, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $2 | $3.25 | n/a | 20 | May 20, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $0.0005 | n/a | 53 | Sep 22, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $0.000001 | n/a | 25 | Dec 6, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $70 → $75 | $13.75 | n/a | 57 | Nov 17, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $7 → $8 | $4.00 | n/a | 48 | Nov 10, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $35 | $2.42 | n/a | 11 | Nov 6, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $300 → $310 | $191.79 | n/a | 50 | Oct 24, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $173 → $170 | $321.31 | n/a | 43 | Oct 24, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $112 → $113 | $237.63 | n/a | 41 | Oct 22, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $2.3 → $1 | $0.40 | n/a | 13 | May 23, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $8 → $4 | $19.40 | n/a | 4 | Feb 9, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $149 → $145 | $179.63 | n/a | 2 | May 7, 2015 |
Alpha Teknova
Aug 11, 2026
Upgraded: Buy
Price Target: $8
Current: $6.72
Upside: +19.05%
Natera
Aug 7, 2026
Reiterated: Buy
Price Target: $290 → $320
Current: $318.35
Upside: +0.52%
Caris Life Sciences
Aug 7, 2026
Reiterated: Buy
Price Target: $32 → $33
Current: $23.40
Upside: +41.03%
CareDx
Aug 6, 2026
Reiterated: Buy
Price Target: $45 → $60
Current: $47.07
Upside: +27.47%
BillionToOne
Aug 6, 2026
Reiterated: Buy
Price Target: $142 → $130
Current: $98.65
Upside: +31.78%
Exagen
Aug 5, 2026
Reiterated: Buy
Price Target: $8 → $9
Current: $6.64
Upside: +35.54%
SOPHiA GENETICS
Aug 5, 2026
Reiterated: Buy
Price Target: $8 → $9
Current: $7.67
Upside: +17.34%
GeneDx Holdings
Aug 4, 2026
Reiterated: Buy
Price Target: $90
Current: $77.88
Upside: +15.56%
Castle Biosciences
Aug 3, 2026
Reiterated: Buy
Price Target: $40 → $44
Current: $32.35
Upside: +36.01%
Tempus AI
Aug 3, 2026
Reiterated: Buy
Price Target: $80 → $70
Current: $55.06
Upside: +27.13%
Jul 31, 2026
Reiterated: Buy
Price Target: $190 → $195
Current: $167.21
Upside: +16.62%
Jul 30, 2026
Reiterated: Buy
Price Target: $24 → $25
Current: $25.45
Upside: -1.77%
Jul 28, 2026
Reiterated: Hold
Price Target: n/a
Current: $16.63
Upside: -
Jul 20, 2026
Maintained: Buy
Price Target: $11 → $16
Current: $14.50
Upside: +12.07%
May 15, 2026
Reiterated: Hold
Price Target: n/a
Current: $4.77
Upside: -
May 15, 2026
Reiterated: Buy
Price Target: $2.5
Current: $0.9611
Upside: +160.12%
May 13, 2026
Reiterated: Hold
Price Target: n/a
Current: $1.21
Upside: -
May 13, 2026
Reiterated: Buy
Price Target: $7 → $4
Current: $0.454
Upside: +781.06%
May 1, 2026
Upgraded: Buy
Price Target: $4
Current: $2.52
Upside: +58.73%
Mar 12, 2026
Rated: Sell
Price Target: $9 → $5
Current: $7.65
Upside: -34.64%
Feb 26, 2026
Reiterated: Buy
Price Target: $160
Current: $74.83
Upside: +113.82%
Feb 3, 2026
Reiterated: Buy
Price Target: $830 → $800
Current: $595.76
Upside: +34.28%
Aug 22, 2025
Reiterated: Hold
Price Target: n/a
Current: $1.16
Upside: -
May 20, 2024
Maintained: Buy
Price Target: $2
Current: $3.25
Upside: n/a
Sep 22, 2023
Rated: Hold
Price Target: n/a
Current: $0.0005
Upside: n/a
Dec 6, 2019
Rated: Hold
Price Target: n/a
Current: $0.000001
Upside: n/a
Nov 17, 2019
Maintained: Buy
Price Target: $70 → $75
Current: $13.75
Upside: n/a
Nov 10, 2019
Maintained: Hold
Price Target: $7 → $8
Current: $4.00
Upside: n/a
Nov 6, 2019
Maintained: Buy
Price Target: $35
Current: $2.42
Upside: n/a
Oct 24, 2019
Maintained: Hold
Price Target: $300 → $310
Current: $191.79
Upside: n/a
Oct 24, 2019
Maintained: Hold
Price Target: $173 → $170
Current: $321.31
Upside: n/a
Oct 22, 2019
Maintained: Buy
Price Target: $112 → $113
Current: $237.63
Upside: n/a
May 23, 2018
Downgraded: Hold
Price Target: $2.3 → $1
Current: $0.40
Upside: n/a
Feb 9, 2016
Reiterated: Hold
Price Target: $8 → $4
Current: $19.40
Upside: n/a
May 7, 2015
Maintained: Hold
Price Target: $149 → $145
Current: $179.63
Upside: n/a